SCHEDULE: Bio Green Med CEO Boosts Stake to 20.58%

Datuk Dr. Doris Wong Sing Ee, CEO of Bio Green Med Solution, Inc., increased her beneficial ownership to 20.58% through a $6.3 million private purchase and an equity grant.

Summary

• Datuk Dr. Doris Wong Sing Ee, Chief Executive Officer and Executive Director of Bio Green Med Solution, Inc., beneficially owns 1,111,131 shares of common stock, representing 20.58% of the class.
• This ownership includes shares purchased in a private transaction for an aggregate price of $6.3 million, which closed on February 26, 2025.
• Additional shares were granted on November 12, 2025, under the Issuer's 2018 Equity Incentive Plan for services rendered.
• Her appointment as Chief Executive Officer and Executive Director was in connection with the share purchase.
• The percentage of ownership is adjusted for a 1-for-16 reverse stock split on May 12, 2025, and a 1-for-15 reverse stock split on July 7, 2025.
• The reporting person has no current plans for further acquisitions, dispositions, extraordinary corporate transactions, material asset sales, changes to the board or management (beyond her appointment), material changes to capitalization or dividend policy, or other significant corporate structure changes.

Sentiment

Score: 6

Explanation: The significant insider ownership by the CEO is a positive sign of commitment and alignment. However, the mention of two recent reverse stock splits suggests the company has faced significant challenges, tempering overall sentiment despite the insider confidence.

Positives

• The Chief Executive Officer and Executive Director, Datuk Dr. Doris Wong Sing Ee, has significantly increased her personal stake in the company to 20.58%, demonstrating strong alignment of interests with shareholders.
• Her appointment as CEO and Executive Director, concurrent with a substantial personal investment, suggests a committed leadership.

Negatives

• The filing mentions two reverse stock splits (1-for-16 on May 12, 2025, and 1-for-15 on July 7, 2025), which often indicate a company's stock price has fallen significantly and it is attempting to maintain listing requirements or improve market perception.

Risks

• The filing does not explicitly list risks, but the context of two recent reverse stock splits (May 12, 2025, and July 7, 2025) implies underlying operational or financial challenges that led to the need for such actions.

Future Outlook

The reporting person, Datuk Dr. Doris Wong Sing Ee, currently has no plans or proposals for further acquisitions or dispositions of the Issuer's securities, extraordinary corporate transactions, material asset sales, changes to the board or management (beyond her current appointment), material changes to capitalization or dividend policy, or other significant alterations to the Issuer's business or corporate structure.

Management Comments

• Datuk Dr. Doris Wong Sing Ee's present principal occupation is Chief Executive Officer and Executive Director of the Issuer.
• Subject to ongoing evaluation, except as set forth above, the Reporting Person has no current plans or proposals which relate to or would result in any of the following: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization, or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the Issuer; (f) Any other material change in the Issuer's business or corporate structure...

Industry Context

Bio Green Med Solution, Inc.'s name suggests involvement in the biotechnology, green technology, or medical solutions sectors. The significant insider ownership by the CEO, following a substantial investment and equity grant, could be interpreted as a vote of confidence in the company's future within its industry, especially after recent reverse stock splits which often occur in companies facing challenges or seeking to re-position themselves.

Comparison to Industry Standards

• This filing primarily details a change in beneficial ownership and management, rather than operational or financial results that can be directly compared to industry benchmarks.
• However, a CEO holding over 20% of a company's stock is a substantial stake, often seen as a positive indicator of management's commitment and alignment with shareholder interests, a characteristic often observed in successful founder-led or turnaround situations across various industries.

Management Changes

Corporate Governance

Legal Proceedings

• No legal proceedings involving Datuk Dr. Doris Wong Sing Ee were reported in the last five years.

Related Party Transactions

• Datuk Dr. Doris Wong Sing Ee purchased shares in a private transaction from a certain shareholder of the Issuer for $6.3 million.
• Datuk Dr. Doris Wong Sing Ee was granted shares under the Issuer's 2018 Equity Incentive Plan for services rendered.

Stakeholder Impact

• Shareholders: Increased insider ownership by the CEO could be viewed positively, signaling confidence and alignment of interests. However, the context of reverse stock splits might concern existing shareholders about past performance.
• Management/Employees: The appointment of a new CEO and Executive Director signifies a change in leadership, potentially impacting strategic direction and corporate culture.

Next Steps

• Ongoing evaluation by the Reporting Person regarding future plans for the Issuer.

Key Dates

Recommendation

While the significant insider investment and leadership commitment from CEO Datuk Dr. Doris Wong Sing Ee are positive indicators of potential future stability and growth, the recent history of two reverse stock splits suggests underlying challenges. Investors should hold to observe the impact of the new leadership and strategic direction before making further investment decisions, as the company appears to be in a transitional phase.

Keywords

Bio Green Med Solution, BGMS, Schedule 13D, Doris Wong Sing Ee, CEO, Executive Director, Share Ownership, Beneficial Ownership, Equity Incentive Plan, Reverse Stock Split, Private Transaction, SEC Filing